Ocuphire Pharma Inc (OCUP)

$3.73 0.04 (1.06%)

16:00 EDT OCUP Stock Quote Delayed 30 Minutes

Why Is Ocuphire Pharma (OCUP) Stock Down 20% Today?

By William White, InvestorPlace Writer Jan 26, 2023

Ocuphire Pharma (OCUP) stock is falling on Thursday after the company posted mixed results from a Phase 2 clinical trial.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 49,173

Day's Range $3.65 - $3.85

52-Week Range $1.78 - $4.43

Dividend & Yield N/A (N/A)

OCUP Stock Predictions, Articles, and Ocuphire Pharma Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 24, 2021

We're starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 1, 2021

Good morning, investor! We're starting the day off with a deep dive into the biggest pre-market stock movers for Thursday!

OCUP stock rises as eye therapy goes under FDA review (NASDAQ:OCUP)

From Seeking Alpha Feb 13, 2023

Ocuphire Pharma (OCUP) gained ~9% pre-market Monday after announcing that the FDA accepted its marketing application for experimental eye drop Nyxol. Read the full story here.

OCUP stock defended at Cantor despite trial setback (NASDAQ:OCUP)

From Seeking Alpha Jan 26, 2023

Ocuphire Pharma (OCUP) shares crashed Thursday even as Cantor Fitzgerald reaffirmed its Overweight rating and $24 price target despite a trial setback. Read the full story here.

Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP) and Irhythm Technologies (IRTC)

From TipRanks Dec 6, 2022

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ocuphire Pharma (OCUP – Research Report) and Irhythm...

JonesTrading Remains a Buy on Ocuphire Pharma (OCUP)

From TipRanks Nov 23, 2022

JonesTrading analyst Sean Kim PhD reiterated a Buy rating on Ocuphire Pharma (OCUP – Research Report) today and set a price target of $16.00. The company&#821...

JonesTrading Remains a Buy on Ocuphire Pharma (OCUP)

From TipRanks Nov 7, 2022

In a report released today, Sean Kim PhD from JonesTrading maintained a Buy rating on Ocuphire Pharma (OCUP – Research Report), with a price target of $23.00....

H.C. Wainwright Keeps Their Buy Rating on Ocuphire Pharma (OCUP)

From TipRanks Nov 7, 2022

In a report released today, Matthew Caufield from H.C. Wainwright reiterated a Buy rating on Ocuphire Pharma (OCUP – Research Report), with a price target of ...